Dr. Oshinski is known for his efforts at advancing the collaboration between Emory University and the Georgia Institute of Technology, as well as his dedication to advancing the technologies of MR imaging. He received his undergraduate degree from Kalamazoo College and BS, MS, and PhD from Georgia Institute of Technology. The underlying mission of his research is the application of engineering principles and technical problem-solving techniques to current clinical problems in the imaging, diagnosis, and treatment of cardiovascular disease. His research has concentrated on developing imaging applications that directly impact disease diagnosis and patient care.

Candace C. Fleischer, PhD, is an Assistant Professor in the Department of Radiology and Imaging Sciences at the Emory University School of Medicine. Dr. Fleischer also holds a faculty appointment at the Wallace H. Coulter Department of Biomedical Engineering at Georgia Institute of Technology and Emory University. She serves as the director of the Biomedical Spectroscopy and Imaging Laboratory.

Dr. Fleischer is a spectroscopist with formal training in physical chemistry and biomedical engineering. Her research group is highly collaborative and focused on the development of new MR spectroscopy and imaging technologies for biomedical and translational applications. 

Current projects include the development of magnetic resonance-based methods for identifying inflammatory biomarkers in malignant brain tumors; and creating new tools for non-invasively measuring brain temperature with applications in cerebrovascular and cardiovascular injury. Her laboratory is also committed to community outreach and increasing scientific literacy.

Guy Benian is a professor of cell biology and pathology in the Department of Pathology and Laboratory Medicine at Emory University School of Medicine. His research focus is on myofibril assembly and maintenance in the model genetic system, Caenorhabditis elegans; focus on the functions and structures of giant multi-domain proteins, and the mechanism by which myofibrils are attached to the muscle cell membrane and transmit force.

Steven L. Goudy, MD, MBA, professor of otolaryngology, director of pediatric otolaryngology at Emory University School of Medicine, founding director of the ACGME-accredited pediatric otolaryngology fellowship at Emory, and medical director of otolaryngology at Childrens Healthcare of Atlanta, is dedicated to providing top-level surgical care to the children of Georgia. 

His clinical practice focuses on maxillary development, Pierre Robin sequence, vascular malformations, and velopharyngeal insufficiency. Working closely with colleagues at the Centers for Disease Control and Prevention, Georgia Institute of Technology, and other local and state entities, Dr. Goudy and his team have developed novel and innovative solutions for care delivery that have brought value to families and improved treatment for patients. 

Dr. Goudys research is focused on defining the biologic processes that guide facial formation for the development of better approaches to regenerating damaged and deficient facial bone and improving wound healing after surgery or injury. Current research projects include an NIH-funded studies to develop immunological approaches to improving oral cavity wound healing, leveraging the oral microbiome to improve oral wound healing and a project to devise cranial facial bone regeneration techniques for pediatric bone replacement procedures. 

Dr. Goudy is dedicated to international service, particularly in the areas of surgical education and delivering surgical care to children with limited access to healthcare. He has traveled globally and performed mission work for more than 20 years in such countries as Guatemala and the Philippines, providing free surgical care to patients with cleft lip and cleft palate and engaging in medical education activities.

Adam M. Klein, MD, FACS, is Willard and Lillian Hackerman Professor in Voice in the Department of Otolaryngology at Emory University School of Medicine. Dr. Klein serves as Director of the Emory Voice Center and as Chief of the Division of Laryngology. Board certified with the American Board of Otolaryngology, Dr. Klein's clinical specialties include general otolaryngology, laryngeal disorders and the professional voice. 

Dr. Klein is a member of the Cancer Prevention and Control Research Program at Winship Cancer Institute. He is a Fellow of The American College of Surgeons and American Laryngological Association. He holds professional memberships with American Academy of Otolaryngology-Head and Neck Surgery, American Broncho-Esophagological Association, and Georgia Society for Otolaryngology.

Dr. Nicholas M. Boulis is a neurosurgeon in Atlanta, Georgia and is affiliated with multiple hospitals in the area, including Emory University Hospital Midtown and Grady Memorial Hospital. He received his medical degree from Harvard Medical School and has been in practice for more than 20 years.

Dr. Gross’s research interests include: restorative approaches (including cell and gene therapy) for Parkinson's disease and other neurodegenerative disorders; physiology of movement disorders (Parkinson's disease, tremor, dystonia); novel surgical techniques for epilepsy (e.g. deep brain stimulation, cell and gene therapy). In particular, he has been elucidating the role of axon guidance molecules in the development and reconstruction of the nigrostriatal pathway, which degenerates in P.D. This approach, which encompasses molecular and cellular engineering in combination with neurotransplantation, may be generally useful in reconstructive approaches for many types of nervous system degeneration and injury. 

In July of 2007, Dr. Gross, along with Steve M. Potter, Ph.D. of the Department of Biomedical Engineering at the Georgia Institute of Technology and Emory University, was the recipient of a prestigious grant from The Epilepsy Research Foundation (ERF) for translational research funding awards supporting innovative epilepsy products. The grant supports the development of a novel electrical stimulation approach that directly controls the activity of the brain to attain a more stable state from which seizures will not arise.

Dr. Waller specializes in bone marrow transplants for acute leukemia, myelodysplastic syndrome, myeloproliferative neoplasms, lymphoma, aplastic anemia, sickle cell disease and in the management of graft-versus-host disease.

David G. Lynn has contributed in the general areas of molecular recognition, synthetic biology and chemical evolution, and has developed chemical and physical methods for the analysis of supramolecular self-assemblies, of signal transduction in cellular development and pathogenesis, of molecular skeletons for storing and reading information, and of the evolution of biological order.

Lynn has earned a Howard Hughes Medical Institute Professorship, the Emory Scholar-Teacher Award, a fellowship from the American Association for the Advancement of Science, and the ACS Charles H. Herty Medal.

During his tenure as Chair of the Department of Chemistry from 2006-2015, Lynn assisted in the renovation of the Atwood chemistry building. In 2018 and 2019, Lynn also served as a board member for the Atlanta Science Festival.

Khalid Salaita is the Samuel Candler Dobbs Professor of Chemistry, and Director for Graduate Studies in the Chemistry Department at Emory University in Atlanta, Georgia (USA). Khalid grew up in Jordan and moved to the US in 1997 to pursue his undergraduate studies at Old Dominion University in Norfolk, Virginia (USA). He worked under the mentorship of Prof. Nancy Xu studying the spectroscopic properties of plasmonic nanoparticles. He then obtained his Ph.D. with Prof. Chad Mirkin at Northwestern University (Evanston, IL) in 2006. 

During that time, he studied the electrochemical properties of organic adsorbates patterned onto gold films and developed massively parallel scanning probe lithography approaches. From 2006-2009, Khalid was a postdoctoral scholar with Prof. Jay T. Groves at the University of California at Berkeley (USA) where he investigated the role of receptor clustering in modulating cell signaling. In 2009, Khalid started his own lab at Emory University, where he is currently investigating the use of nucleic acids as molecular force sensors, smart drugs, and synthetic motors. 

In recognition of his independent work, Khalid has received a number of awards, most notably: the Alfred P. Sloan Research Fellowship, the Camille-Dreyfus Teacher Scholar award, the National Science Foundation Early CAREER award, the Kavli Fellowship, and Merck Future Insight Prize. Khalid is currently the director of the Center on Probes for Molecular Mechanotechnology, and an Associate Editor of SmartMat. Khalid’s program has been supported by NSF, NIH, and DARPA.